IDEXX LABORATORIES INC /DE Proceeds from Lines of Credit
IDEXX LABORATORIES INC /DE (IDXX) reported Proceeds from Lines of Credit of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2021-05-04
- IDEXX LABORATORIES INC /DE proceeds from lines of credit for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- IDEXX LABORATORIES INC /DE proceeds from lines of credit for the quarter ending 2020-03-31 was $198.11M.
| Period end | Proceeds from Lines of Credit 3 month |
|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-04 |
| 2020-03-31 | $198.11M 10-Q · filed 2021-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |